Brief: QYUNS Therapeutics Posts HY Adjusted Profit Of RMB202.5 MLN
19/08/2026 14:18
BRIEF-QYUNS Therapeutics Posts HY Adjusted Profit Of RMB202.5 MLN Aug 19 (Reuters) - QYUNS Therapeutics HY Adjusted profit RMB202.5 MLN.
- QYUNS Therapeutics HY Revenue 424.1 MLN
Recent news on Qyuns Therapeutics
See all newsBrief: QYUNS Therapeutics Posts HY Adjusted Profit Of RMB202.5 MLN
Brief: Qyuns Therapeutics Says Qx027n Obtains Two Clinical Trial Approvals For Copd, Chronic Rhinosinusitis
Brief: Qyuns Therapeutics Says Saifu Juli To Buy 34% Of Cellularforce For RMB86.02 Million
Brief: Qyuns Therapeutics Repurchases 3.43 Million Shares As Treasury Shares From Nov 6, 2025 To June 9
Brief: Qyuns Therapeutics Co Receives Milestone Payment From Roche